US Stock MarketDetailed Quotes
MBIO Mustang Bio
- 0.1951
- -0.0100-4.88%
Close Nov 25 16:00 ET
- 0.1951
- 0.00000.00%
Pre 08:54 ET
9.32MMarket Cap-146P/E (TTM)
0.2167High0.1950Low691.77KVolume0.2100Open0.2051Pre Close142.10KTurnover1.56%Turnover RatioLossP/E (Static)47.78MShares1.660052wk High-1.08P/B8.64MFloat Cap0.128152wk Low--Dividend TTM44.28MShs Float200.2500Historical High--Div YieldTTM10.58%Amplitude0.1281Historical Low0.2050Avg Price1Lot Size
About Mustang Bio Company
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
Company Profile
SymbolMBIO
Company NameMustang Bio
Listing DateAug 22, 2017
CEODr. Manuel Litchman, M.D.
MarketNASDAQ
Employees80
Fiscal Year Ends12-31
Address377 Plantation Street,1st floor
CityWorcester
ProvinceMassachusetts
CountryUnited States of America
Zip Code01605-2245
Phone1-781-652-4500
Websitehttp://www.mustangbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Manuel Litchman, M.D.
- Director, Interim Chief Financial Officer, President and Chief Executive Officer
- 656.67K
- Michael S. Weiss
- Executive Chairman of the Board
- 110.00K
- David Jin
- Director
- --
- Dr. Lindsay A. Rosenwald, M.D.
- Director
- 100.00K
- Dr. Michael J. Zelefsky, M.D.
- Independent Director
- 100.00K
- Neil Herskowitz
- Independent Director
- 100.00K
- Adam J. Chill
- Independent Director
- 110.00K
- Peter Carney
- Controller
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data